1. Club Cell Protein, CC10, Attenuates Acute Respiratory Distress Syndrome Induced by Smoke Inhalation.
- Author
-
Lopez E, Fujiwara O, Nelson C, Winn ME, Clayton RS, Cox RA, Hawkins HK, Andersen CR, Wade CE, Hariprakasha H, Prough DS, Pilon AL, and Enkhbaatar P
- Subjects
- Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Pulmonary Edema etiology, Pulmonary Edema prevention & control, Recombinant Proteins, Respiratory Distress Syndrome etiology, Sheep, Respiratory Distress Syndrome prevention & control, Smoke Inhalation Injury complications, Uteroglobin therapeutic use
- Abstract
Objectives: To evaluate the dose effects of Recombinant human Club cell 10-kDa protein (rhCC10) on lung function in a well-characterized ovine model of acute respiratory distress syndrome (ARDS) induced by smoke inhalation injury (SII); specifically, the potential of rhCC10 protein to control the inflammatory response and protect pulmonary tissue and function following SII., Design: Randomized, controlled, prospective, and large animal translational studies., Setting: University large animal intensive care unit., Subjects: Thirty-six adult female sheep were surgically prepared and allocated into five groups (Sham (no SII), n = 6; 1 mg/kg/d CC10, n = 8; 3 mg/kg/d CC10, n = 7; 10 mg/kg/d CC10, n = 8; Control SII, n = 7)., Interventions: All groups except the sham group were subjected to SII with cooled cotton smoke. Then, the animals were placed on a ventilator, treated with 1, 3, and 10 mg/kg/d of intravenous rhCC10 or vehicle, divided evenly into two administrations per day every 12 h, fluid resuscitated, and monitored for 48 h in a conscious state., Measurements and Main Results: The group treated with 10 mg/kg/d rhCC10 attenuated changes in the following variables: PaO2/FiO2 ratio, oxygenation index, and peak inspiratory pressure; neutrophil content in the airway and myeloperoxidase levels; obstruction of the large and small airways; systemic leakage of fluid and proteins, and pulmonary edema., Conclusions: In this study, high-dose rhCC10 significantly attenuated ARDS progression and lung dysfunction and significantly reduced systemic extravasation of fluid and proteins, normalizing fluid balance. Based on these results, rhCC10 may be considered a novel therapeutic option for the treatment of SII-induced ARDS.
- Published
- 2020
- Full Text
- View/download PDF